CKD Bio Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported negative sales was KRW 0.00042 million compared to sales of KRW 0.0006 million a year ago. Net loss was KRW 6,397.7 million compared to KRW 3,500.23 million a year ago. Basic loss per share from continuing operations was KRW 1,166 compared to KRW 638 a year ago. Basic loss per share was KRW 1,166 compared to KRW 638 a year ago.
For the nine months, negative sales was KRW 0.00028 million compared to KRW 0.00071 million a year ago. Net loss was KRW 16,055.79 million compared to KRW 9,628.27 million a year ago. Basic loss per share from continuing operations was KRW 2,927 compared to KRW 1,755 a year ago. Basic loss per share was KRW 2,927 compared to KRW 1,755 a year ago.